Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

(2013) J K Hicks et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Cytochrome P450 2D6 Phenoconversion Is Common in Patients Being Treated for Depression

(2013) Sheldon H. Preskorn et al.   JOURNAL OF CLINICAL PSYCHIATRY

Genetic differences in cytochrome P450 enzymes and antidepressant treatment response

(2013) Karen Hodgson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Applications of CYP450 Testing in the Clinical Setting

(2013) C. F. Samer et al.   Molecular Diagnosis & Therapy

Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

(2013) Ulrich M. Zanger et al.   PHARMACOLOGY & THERAPEUTICS

Personalized medicine: is it a pharmacogenetic mirage?

(2012) Rashmi R. Shah et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Composite Functional Genetic and Comedication CYP2D6 Activity Score in Predicting Tamoxifen Drug Exposure Among Breast Cancer Patients

(2010) Silvana Borges et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Cytochrome P450 2D6 Phenotype Predicts Antidepressant Efficacy of Venlafaxine

(2010) Kasia W. Lobello et al.   JOURNAL OF CLINICAL PSYCHIATRY

CYP2C19 variation and citalopram response

(2010) David A. Mrazek et al.   Pharmacogenetics and Genomics

Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response

(2010) Ming-Hsien Tsai et al.   PHARMACOGENOMICS

Practical recommendations for pharmacogenomics-based prescription: 2010 ESF–UB Conference on Pharmacogenetics and Pharmacogenomics

(2010) Laurent Becquemont et al.   PHARMACOGENOMICS

Cytochrome P450 2D6 Genotyping

(2009) Julia Kirchheiner et al.   CNS DRUGS

Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients

(2009) Alessandro Serretti et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

5-HTTLPR modulates antidepressant efficacy in depressed women

(2009) Florence Gressier et al.   PSYCHIATRIC GENETICS

Pharmacokinetic Genes Do Not Influence Response or Tolerance to Citalopram in the STAR*D Sample

(2008) Eric J. Peters et al.   PLoS One